|Articles|March 1, 2002

Opening the door to exercise for teens with chronic pulmonary disease

Enabling adolescents with chronic pulmonary disease to exercise or play sports regularly can improve their health. The keys are to arrive at the proper diagnosis, prescribe the right treatment, and recommend the most appropriate activity.

Newsletter

Access practical, evidence-based guidance to support better care for our youngest patients. Join our email list for the latest clinical updates.

Subscribe

Related Content

CBT and fluoxetine show comparable improvement for pediatric anxiety

ByBradley Peterson, MD

August 26th 2026

FDA approves dolutegravir dispersible tablets for HIV-infected newborns

ByMorgan Ebert, Executive Editor

August 26th 2026

FDA authorizes Avulux light-filtering lenses for migraine-associated light sensitivity in patients 12 and older

ByMorgan Ebert, Executive Editor

August 26th 2026

FDA authorizes first dual glucose-ketone monitor for children as young as 2

ByMorgan Ebert, Executive Editor

August 25th 2026

FDA approves nipocalimab as first treatment for warm autoimmune hemolytic anemia

ByMorgan Ebert, Executive Editor

August 25th 2026

Latest CME

Video

Progress in Hyperlipidemia Management to Reduce ASCVD Risk: An Illustrated Update

Nihar R. Desai, MD, MPH; Martha Gulati, MD, MS, FACC, FAHA, MASPC, FESC, FSCCT (hon), FRCP Edin

Opening the door to exercise for teens with chronic pulmonary disease

Related Content

CBT and fluoxetine show comparable improvement for pediatric anxiety

FDA approves dolutegravir dispersible tablets for HIV-infected newborns

FDA authorizes Avulux light-filtering lenses for migraine-associated light sensitivity in patients 12 and older

FDA authorizes first dual glucose-ketone monitor for children as young as 2

FDA approves nipocalimab as first treatment for warm autoimmune hemolytic anemia

Latest CME

Progress in Hyperlipidemia Management to Reduce ASCVD Risk: An Illustrated Update

Trending on Contemporary Pediatrics

FDA authorizes Avulux light-filtering lenses for migraine-associated light sensitivity in patients 12 and older

Mental health treatment increases among US children and teens

FDA approves dolutegravir dispersible tablets for HIV-infected newborns

FDA authorizes first dual glucose-ketone monitor for children as young as 2

Lebrikizumab phase 3 data show improvements in atopic dermatitis symptoms, itch in children